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Purpose/Objective: State of the art treatment of locally 
advanced cervical cancer with image guided intensity 
modulated external radiotherapy followed by image guided 
brachytherapy provide good clinical outcome. However, 
there are still 10-15% loco-regional failures and 10-20% who 
experience moderate to severe side effects. In the current 
work we propose to use FDG PET as basis for a short-course 
simultaneous integrated boost (SIB) with external beam 
therapy. This concept may increase tumour control and 
improve tumour shrinkage before brachytherapy. The latter 
may reduce complexity and improve organ sparing at 
brachytherapy. 
Materials and Methods: This study included 10 patients with 
locally advanced cervical cancer all treated with curative 
image guided external beam and brachytherapy. FDG PET/CT 
was obtained prior to therapy for all patients. To explore the 
potential use of PET based dose escalation, a new approach 
was tested in silico. Here, the FDG avid tumour volume was 
dose escalated by intensity modulated radiotherapy from the 
conventional 1.8Gy to 2.8Gy per fraction for the 10 first 
fractions; a short-course SIB. For the remaining 18 external 
beam fractions, standard treatment to the pelvic area is 
followed to a total dose to the PTV and boost volume of 
50.4Gy and 60.4Gy, respectively. For intensity modulation, 
both photons and protons were considered using dual arc 
VMAT and three-field IMPT, respectively. All treatment plans 
were generated using the Eclipse Treatment Planning System 
(v.11, Varian Medical Systems, Palo Alto, CA). 
Results: For the patients included, the PET based boost 
volume had a mean volume of 36 ± 6cm3 as compared to 
average volumes for the GTV and PTV of 69 ± 10cm3 and 1508 
± 55cm3, respectively. The dose escalation was 
straightforward to implement for both VMAT and IMPT, with a 
D98 ≥ 95% for the boost volume being achieved in all cases. 
The sum of the short-course SIB (10 fractions) and the 
subsequent 18 conventional fractions was compared to the 
conventional, 28-fraction non-SIB approach by analysing dose 
volume histograms (Table 1). Only marginal increased doses 
to the relevant organs at risk (OARs) were found for all 
investigated parameters. IMPT had, compared to VMAT, 
reduced OAR doses in the intermediate dose range, but 
showed no relative advantage in dose escalation.  
 
 
Conclusions: The additional 1Gy per fraction to the boost 
volume could be achieved in all patients with only minor 
increase of OAR dose using both VMAT and IMPT. This short-
course approach may prove beneficial in terms of reduced 
impact of anatomical changes during dose escalation and 
allowing time for enhanced tumour shrinkage before 
brachytherapy. Thus, this novel concept may prove clinically 
valuable, in particular for patients with large tumours.  
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Purpose/Objective: To investigate the influence of Monte 
Carlo (MC) dose calculation settings on the proton dose 
distribution. Different phantom geometries and patient cases 
were evaluated with focus on dose calculation accuracy and 
clinical applicability including benchmarking against pencil 
beam (PB) calculations. 
Materials and Methods: MC calculation settings like 
maximum number of particles (5x103-5x105), mean relative 
statistical uncertainty per spot (MRSU = 1-5%) and the MRSU 
threshold (th) (10-60% of maximum dose per spot) for voxels 
included in uncertainty considerations were tested for a 
proton MC algorithm (XiO research version v4.62, Elekta AB, 
Stockholm, Sweden). The clinically used PB algorithm 
including heterogeneity corrections, nuclear interactions and 
energy dependent stopping power ratios1,2 was used for 
benchmarking. All plans were optimized with the PB and 
recalculated using the MC algorithm. 
The phantom consisted of 10 chess pattern cubes of 
10x20x9.6 mm³ with alternating HUs of +1000 (bone) and -
800 (lung) embedded in a water tank. Target structures were 
located within or at varying distances behind the chess 
pattern and irradiated from different directions. A prostate 
(2 opposing beams) and a paranasal sinus (PS) cancer patient 
(3 beams) served as clinical test cases. The results were 
evaluated by means of dose difference maps, γ-index analysis 
(2%/2mm), homogeneity (HI), conformity (CI) and dose 
volume measures. 
1 Soukup et al 2005 PMB 50 
2 Fippel et al 2004 MedPhys 31 
Results: For an accurate dose calculation up to 5x104 
particles were required using a MRSU of 3-5% and up to 5x105 
for under 3%. γ-index analysis (PB dose as reference) for 
plans with a beam entrance angle of 15% revealed a γmean of 
0.5 and γ1% of 3.2, with a failure rate of 13.7% in an area of 3 
cm around the target (Figure 1a). For targets distal to the 
chess pattern the main factor influencing dose differences 
was the distance to the inhomogeneities. The CI was 0.84 for 
the PB and 8.3% less for the MC at a distance of 1 cm, 
irrespectively of the settings. At 3 cm distance negligible 
differences were found between MC and PB.  
Dose calculation for a prostate plan lasted 21 s for the PB 
algorithm. For MC the dose calculation time was higher by a 
factor of 4 (MRSU = 5%) and 78 (MRSU = 1%). D2% and the HI 
increased from 102% to 104% and 0.09 to 0.12 using MC 
instead of PB. These differences showed a decreasing 
tendency for more accurate MC settings. For the PS patient 
the heterogeneous tissue in the brain together with the 
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proximity of the target to the surface caused higher 
variations (Fig. 1c).  
Comparing different MC settings to each other, dose 
differences were equally distributed over the target region. 
Almost 100% of the voxels passed the γ-index analysis for 
patient and phantom plans (Fig. 1b, d).  
 
 
 
Conclusions: For a clinically acceptable MC dose distribution 
a MRSU of 5% seems appropriate, especially with respect to 
dose calculation time.The PB algorithm was found to deliver 
comparable results even in more complex treatment planning 
situations where heterogeneities are involved. 
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Purpose/Objective: Knowledge-based planning (KBP) aims to 
automate plan optimization, increase efficiency and reduce 
inter and intra-planner variation. RapidPlan™ (Varian Medical 
Systems) uses a library of patient plans to create a model 
that predicts a range of achievable dose-volume histograms 
(DVHs) for new patients and uses these for setting 
optimization objectives. We benchmarked RapidPlan KBP 
versus clinical plans for two patient groups, using three 
different libraries. 
Materials and Methods: Volumetric modulated arc therapy 
(VMAT) plans of 60 recent head and neck cancer patients that 
included sparing of the salivary glands, swallowing muscles 
and oral cavity, were evenly divided between two libraries, 
30A and 30B. Three models were created, Model30A, Model30B 
and Model60, the latter by combining libraries 30A and 30B. 
Knowledge-based RapidArc plans were created for two 
evaluation groups; EG1, consisting of 15 recent patients 
where salivary glands, swallowing structures and oral cavity 
were spared, and EG2, consisting of 15 patients from 2008-
2009, shortly after starting our VMAT program, in which only 
the salivary glands were spared. KBP results were compared 
against clinical plans (CP) on the basis of the boost/elective 
planning target volume homogeneity index (HIB/HIE=100*[D2%-
D98%]/D50%) and mean dose to composite salivary glands, 
swallowing muscles and oral cavity (Dsal, Dswal and Doc, 
respectively).  
Results: For EG1, KBP improved HIB/HIE values over CP by 
1.0-1.3%/1.0-0.6%. Comparable Dsal and Dswal values were seen 
in Model30A/Model30B/Model60, an average 0.1/1.0/0.8Gy and 
4.8/3.7/4.4Gy less than CP Dsal and Dswal, respectively. 
However, differences were noted between individual OARs, 
with Model30B increasing DOC by 0.1/3.2/2.8Gy over 
CP/Model30A/Model60. Plan quality was less consistent when 
the patient was flagged as an ‘outlier’, compared to the 
range of OAR/PTV metrics in the plan library. For EG2, KBP 
decreased Dsal by 4.1-4.9Gy on average, while HIB/HIE 
decreased by 1.1-1.5%/2.3-1.9%. Generating DVH predictions 
and optimizing a KB plan took <36 s and <15 minutes, 
respectively. 
Conclusions: RapidPlan knowledge-based treatment plans 
were comparable to CP if the patient’s OAR/PTV geometry 
was within the range of those included in the models. EG2 
results showed that KBP libraries comprised of plans made by 
an experienced team can substantially improve OAR sparing 
compared to CP made at the start of a VMAT program. The 
present data support the KBP concept, model library sharing 
between institutes using similar clinical plan protocols and 
the use of KBP to shortcut the learning curve for complex 
VMAT planning.  
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Purpose/Objective: Fallback module in RayStation TPS 
allows for an automated generation of 3DCRT, IMRT, and 
VMAT plans from original plans of any modality. The system 
uses a dose mimicking function to create dose distributions as 
similar to the reference one as possible. The aim of this study 
was to evaluate and compare the automatically generated 
VMAT plans with the original Tomotherapy plans; a metric 
that measures the average line distance between the 
sampled curves defined by the generated and reference DVHs 
is used. 
Materials and Methods: Five patients with high risk prostate 
cancer were analyzed. A reference Tomotherapy plan (TP) 
was generated for each patient. For each TP, 4 VMAT fallback 
plans (FP) were generated (with two, three and four arcs 
respectively). Three plans were created with 0 (raw 
fallback), 40 and 80 iterations for each geometry. We took 
into account as relevant dose values: Dmean, D98%, D95% and 
D1% for the PTVs; Dmean, V50, V65, and V75 for the rectum; 
Dmean and V65 for the bladder; V45 for the small bowel and 
Dmean for the bulb. Percentage dose differences (%DD) 
